Studies on the absence of photodynamic mechanism in the normal pancreas

Extraction procedures to quantitate porfimer sodium concentration in tissues were correlated with fluorescence measurements made in vivo, on hamster and rat normal pancreas and intra-pancreatic tumors. The uptake of photosensitizer has been shown to be high in both normal and malignant pancreatic tissues, in both animal models studied. Photobleaching of the drug, as evidenced by both techniques within the pancreatic tumor, occurs in a typical manner during PDT, with resultant tissue destruction. In contrast, when the normal pancreas is exposed to PDT, a negligible photobleaching effect, as well as a lack of tissue response, is observed. The lack of observable response is corroborated by a lack of measurable physiological response. Both serum amylase and serum glucose show acute changes up to 12 hours post treatment but quickly return to normal. HPLC analysis shows that the drug extracted from both the normal pancreas and intrapancreatic tumor is essentially the same as that extracted from other tissues and similar to that which has been injected into the animal. Fluorescence microscopy has shown that at time points between 12-120 hours the drug is associated with lymphatic channels. This would not, however, necessarily preclude normal tissue destruction. Similar results have been found with other photosensitizers. Understanding the lack of response in the pancreas may lead to a deeper understanding of the diseased state which is normally refractory to all therapy as well as understanding the fundamental concepts of the mechanisms of PDT.

[1]  D. Kessel,et al.  Chemical, biologic and biophysical studies on 'hematoporphyrin derivative'. , 1985, Advances in experimental medicine and biology.

[2]  T J Dougherty,et al.  The structure of the active component of hematoporphyrin derivative. , 1984, Progress in clinical and biological research.

[3]  J Moan,et al.  PHOTOBLEACHING OF PORPHYRINS USED IN PHOTODYNAMIC THERAPY AND IMPLICATIONS FOR THERAPY , 1987, Photochemistry and photobiology.

[4]  J. Moan,et al.  Porphyrin-sensitized photoinactivation of cells in vitro. , 1984, Progress in clinical and biological research.

[5]  J. Yager,et al.  Pancreatic carcinoma in azaserine‐treated rats: Induction, classification and dietary modulation of incidence , 1981, Cancer.

[6]  K. Brackett,et al.  Hematoporphyrin derivative uptake and photodynamic therapy in pancreatic carcinoma , 1988, Journal of surgical oncology.

[7]  D. Bockman,et al.  Cells of origin of pancreatic cancer: Experimental animal tumors related to human pancreas , 1981, Cancer.

[8]  Stuart L. Marcus,et al.  Photodynamic therapy of human cancer: clinical status, potential, and needs , 1990, Other Conferences.

[9]  Fitzgerald Pj,et al.  Classification of pancreatic cancer (nonendocrine). , 1979 .

[10]  T. Dougherty,et al.  Intra-abdominal applications of hematoporphyrin photoradiation therapy. , 1983, Advances in experimental medicine and biology.

[11]  F. Mícek [Cancer of the pancreas]. , 1965, Bratislavske lekarske listy.

[12]  D. Longnecker,et al.  Experimental induction of pancreatic carcinomas in the hamster with N delta-(N-methyl-N-nitrosocarbamoyl)-L-ornithine. , 1983, Journal of the National Cancer Institute.

[13]  T. Mang,et al.  PHOTODYNAMIC THERAPY IN THE TREATMENT OF PANCREATIC CARCINOMA: DIHEMATOPORPHYRIN ETHER UPTAKE and PHOTOBLEACHING KINETICS , 1987, Photochemistry and photobiology.

[14]  T J Dougherty,et al.  CHARACTERIZATION OF INTRA‐TUMORAL PORPHYRIN FOLLOWING INJECTION OF HEMATOPORPHYRIN DERIVATIVE OR ITS PURIFIED COMPONENT * , 1987, Photochemistry and photobiology.

[15]  D. Longnecker Animal model of human disease. Carcinoma of the pancreas in azaserine-treated rats. , 1981, The American journal of pathology.

[16]  T. Dougherty,et al.  Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue. , 1979, Cancer research.